Dylan R. Pillai
Papers
1
Total Citations
90
H-Index
1
About
Dylan R. Pillai is a leading infectious disease researcher whose work bridges parasitology, drug discovery, and clinical diagnostics. His primary research areas include malaria pathogenesis, antimalarial drug resistance, and the development of novel therapeutic strategies against *Plasmodium falciparum*. One of his most impactful contributions is a repurposing strategy that identified novel synergistic inhibitors of *P. falciparum* Heat Shock Protein 90 (HSP90). In this landmark 2010 study, cited over 90 times, Pillai and his team performed a robotic high-throughput screen of 4,000 small molecules—including natural compounds and pharmacologically active agents—to uncover compounds that work synergistically to block HSP90, a critical target for parasite survival. This work is especially significant given that malaria causes approximately 3 million deaths annually and drug resistance is widespread. By leveraging existing drug libraries, Pillai’s approach accelerates the discovery of affordable, effective treatments. His research has profound implications for global health, offering a strategic pathway to combat drug-resistant malaria and improve outcomes in resource-limited settings.
Research Focus
Key Achievements
Top Papers
- 1